This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Meena Narsimhan, PhD
Director of Process Technology at Novilytic LLC
Speaker

Profile

Dr. Narsimhan is a biochemist with extensive experience in assay development, molecular biology and genetics. Her wealth of research experience in academia and industry has resulted in 4 issued patents and 47 refereed journal publications (>6200 citations; h-index, 34). The products that she helped to develop are BioCD, a canine disease diagnostic tool (Quadraspec/2008), SYSTEMETRIC® Cell Health Screen (Asedasciences/2018), Proteometer-L (Novilytic/2023) and Proteometer-UFT (Novilytic/2024). Dr. Narsimhan is currently Director of Process Technology at Novilytic, LLC, West Lafayette, Indiana.

Agenda Sessions

  • At-Line Nanoparticle-Based Antibody Molecular Structure Analyses

    12:15pm